DEF 14A: Definitive information statements
8-K: Kintara Therapeutics Announces Fiscal 2024 Third Quarter Financial Results
8-K: Current report
8-K: Current report
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Kintara Therapeutics Announces Fiscal 2024 Second Quarter Financial Results and Provides Corporate Update
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | 8-K: Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update
Kintara Therapeutics | 8-K: Current report
Kintara Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Kintara Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Kintara Therapeutics | 8-K: Current report
No Data